{
  "trial_id": "NCT02127710",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, ECOG performance status, prior treatments, histological confirmation of PRCC, baseline tumor measurements, absolute neutrophil count, hemoglobin level, platelet count, alanine aminotransferase level, aspartate aminotransferase level, total bilirubin level, glomerular filtration rate, International Normalisation Ratio, activated partial thromboplastin time, presence of tumor thrombus or deep vein thrombosis, contraceptive use, ability to swallow oral medications, predicted life expectancy, willingness to comply with study procedures.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "ECOG Performance Status",
          "ECOG performance status"
        ],
        [
          "PRCC Confirmation from Central Laboratory",
          "histological confirmation of PRCC"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Ethnicity (NIH/OMB)",
        "Stage Classification",
        "Renal Cell Classification",
        "MSKCC Risk Group",
        "Weight"
      ],
      "remaining_candidate_features": [
        "prior treatments",
        "baseline tumor measurements",
        "absolute neutrophil count",
        "hemoglobin level",
        "platelet count",
        "alanine aminotransferase level",
        "aspartate aminotransferase level",
        "total bilirubin level",
        "glomerular filtration rate",
        "International Normalisation Ratio",
        "activated partial thromboplastin time",
        "presence of tumor thrombus or deep vein thrombosis",
        "contraceptive use",
        "ability to swallow oral medications",
        "predicted life expectancy",
        "willingness to comply with study procedures."
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, ECOG performance status, Histological subtype, Prior treatments, Hematological function (e.g., absolute neutrophil count, hemoglobin, platelets), Liver function (e.g., ALT, AST, total bilirubin), Renal function (e.g., glomerular filtration rate), Coagulation parameters (e.g., INR, aPTT), Tumor measurements, ",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "ECOG Performance Status",
          "ECOG performance status"
        ],
        [
          "PRCC Confirmation from Central Laboratory",
          "Histological subtype"
        ],
        [
          "Renal Cell Classification",
          "Histological subtype"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Ethnicity (NIH/OMB)",
        "Stage Classification",
        "MSKCC Risk Group",
        "Weight"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "Prior treatments",
        "Hematological function (e.g., absolute neutrophil count, hemoglobin, platelets)",
        "Liver function (e.g., ALT, AST, total bilirubin)",
        "Renal function (e.g., glomerular filtration rate)",
        "Coagulation parameters (e.g., INR, aPTT)",
        "Tumor measurements"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, ECOG Performance Status, Histological confirmation of PRCC, Previous treatment for PRCC, Number of metastatic sites, Presence of tumor thrombus or deep vein thrombosis, Hemoglobin, Absolute neutrophil count, Platelets, Alanine aminotransferase, Aspartate aminotransferase, Total bilirubin, Glomerular filtration rate, International Normalisation Ratio, Activated partial thromboplastin time.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "ECOG Performance Status",
          "ECOG Performance Status"
        ],
        [
          "PRCC Confirmation from Central Laboratory",
          "Histological confirmation of PRCC"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Ethnicity (NIH/OMB)",
        "Stage Classification",
        "Renal Cell Classification",
        "MSKCC Risk Group",
        "Weight"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "Previous treatment for PRCC",
        "Number of metastatic sites",
        "Presence of tumor thrombus or deep vein thrombosis",
        "Hemoglobin",
        "Absolute neutrophil count",
        "Platelets",
        "Alanine aminotransferase",
        "Aspartate aminotransferase",
        "Total bilirubin",
        "Glomerular filtration rate",
        "International Normalisation Ratio",
        "Activated partial thromboplastin time"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ECOG performance status, histological subtype of PRCC, number and location of metastatic sites, prior treatments, duration of PRCC diagnosis, presence of tumor thrombus or deep vein thrombosis, hemoglobin, absolute neutrophil count, platelet count, alanine aminotransferase, aspartate aminotransferase, total bilirubin, glomerular filtration rate, International Normalisation Ratio, activated partial thromboplastin time, systolic blood pressure, diastolic blood pressure, QTc interval.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "ECOG Performance Status",
          "ECOG performance status"
        ],
        [
          "PRCC Confirmation from Central Laboratory",
          "histological subtype of PRCC"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Ethnicity (NIH/OMB)",
        "Stage Classification",
        "Renal Cell Classification",
        "MSKCC Risk Group",
        "Weight"
      ],
      "remaining_candidate_features": [
        "race",
        "number and location of metastatic sites",
        "prior treatments",
        "duration of PRCC diagnosis",
        "presence of tumor thrombus or deep vein thrombosis",
        "hemoglobin",
        "absolute neutrophil count",
        "platelet count",
        "alanine aminotransferase",
        "aspartate aminotransferase",
        "total bilirubin",
        "glomerular filtration rate",
        "International Normalisation Ratio",
        "activated partial thromboplastin time",
        "systolic blood pressure",
        "diastolic blood pressure",
        "QTc interval"
      ]
    }
  }
}